# An fMRI Study of Jianpi Yishen Huatan Granules for Cognitive Impairment After Acute Cerebral Infarction

> **NCT02752867** · NA · UNKNOWN · sponsor: **Dongfang Hospital Beijing University of Chinese Medicine** · enrollment: 40 (estimated)

## Conditions studied

- Cognitive Impairment

## Interventions

- **DRUG:** Jianpi Yishen Huatan Granules
- **OTHER:** the placebo

## Key facts

- **NCT ID:** NCT02752867
- **Lead sponsor:** Dongfang Hospital Beijing University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2019-08
- **Final completion:** 2019-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752867, "An fMRI Study of Jianpi Yishen Huatan Granules for Cognitive Impairment After Acute Cerebral Infarction". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02752867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*